• 760 Citations
  • 13 Scopus h-Index
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Steven Attia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 760 Citations
  • 13 Scopus h-Index
  • 37 Article
  • 3 Review article

Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab

Keung, E. Z., Burgess, M., Salazar, R., Parra, E. R., Rodrigues-Canales, J., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Attia, S., Riedel, R. F., Hu, J., Okuno, S. H., Priebat, D. A., Movva, S., Davis, L. E., Reed, D. R., Reuben, A., Roland, C. L., Reinke, D., Lazar, A. J. & 3 others, Wang, W. L., Wargo, J. A. & Tawbi, H. A., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1258-1266 9 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial

    Younger, E., Ballman, K., Lu, Y., Pápai, Z., Van Tine, B. A., Attia, S., Schöffski, P., Reinke, D., Tap, W. D. & Jones, R. L., Apr 2020, In : Journal of Geriatric Oncology. 11, 3, p. 463-469 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas

    Jones, R. L., Chawla, S. P., Attia, S., Schöffski, P., Gelderblom, H., Chmielowski, B., Le Cesne, A., Van Tine, B. A., Trent, J. C., Patel, S., Wagner, A. J., Chugh, R., Heyburn, J. W., Weil, S. C., Wang, W., Viele, K. & Maki, R. G., Jan 1 2019, In : Cancer.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Incidence and Management of Olaratumab Infusion-Related Reactions

    Van Tine, B. A., Govindarajan, R., Attia, S., Somaiah, N., Barker, S. S., Shahir, A., Barrett, E., Lee, P., Wacheck, V., Ramage, S. C. & Tap, W. D., Nov 1 2019, In : Journal of oncology practice. 15, 11, p. e925-e933

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

    Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S. H., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jun 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

    Research output: Contribution to journalArticle

  • 14 Scopus citations